PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ASND vs. AAPL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ASND and AAPL is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ASND vs. AAPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and Apple Inc (AAPL). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
4.54%
8.52%
ASND
AAPL

Key characteristics

Sharpe Ratio

ASND:

0.01

AAPL:

1.38

Sortino Ratio

ASND:

0.37

AAPL:

1.98

Omega Ratio

ASND:

1.04

AAPL:

1.25

Calmar Ratio

ASND:

0.01

AAPL:

1.98

Martin Ratio

ASND:

0.03

AAPL:

5.95

Ulcer Index

ASND:

15.99%

AAPL:

5.52%

Daily Std Dev

ASND:

43.30%

AAPL:

23.88%

Max Drawdown

ASND:

-61.72%

AAPL:

-81.80%

Current Drawdown

ASND:

-21.16%

AAPL:

-5.46%

Fundamentals

Market Cap

ASND:

$8.62B

AAPL:

$3.67T

EPS

ASND:

-$6.79

AAPL:

$6.31

Total Revenue (TTM)

ASND:

$303.75M

AAPL:

$395.76B

Gross Profit (TTM)

ASND:

$255.59M

AAPL:

$184.10B

EBITDA (TTM)

ASND:

-$196.53M

AAPL:

$134.27B

Returns By Period

In the year-to-date period, ASND achieves a 4.66% return, which is significantly higher than AAPL's -2.22% return. Over the past 10 years, ASND has underperformed AAPL with an annualized return of 22.32%, while AAPL has yielded a comparatively higher 23.89% annualized return.


ASND

YTD

4.66%

1M

12.45%

6M

4.54%

1Y

-7.87%

5Y*

-0.01%

10Y*

22.32%

AAPL

YTD

-2.22%

1M

6.47%

6M

8.52%

1Y

34.80%

5Y*

25.62%

10Y*

23.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ASND vs. AAPL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND
The Risk-Adjusted Performance Rank of ASND is 4343
Overall Rank
The Sharpe Ratio Rank of ASND is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of ASND is 4040
Sortino Ratio Rank
The Omega Ratio Rank of ASND is 3939
Omega Ratio Rank
The Calmar Ratio Rank of ASND is 4545
Calmar Ratio Rank
The Martin Ratio Rank of ASND is 4545
Martin Ratio Rank

AAPL
The Risk-Adjusted Performance Rank of AAPL is 8282
Overall Rank
The Sharpe Ratio Rank of AAPL is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of AAPL is 7878
Sortino Ratio Rank
The Omega Ratio Rank of AAPL is 7676
Omega Ratio Rank
The Calmar Ratio Rank of AAPL is 8989
Calmar Ratio Rank
The Martin Ratio Rank of AAPL is 8383
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ASND vs. AAPL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ASND, currently valued at 0.01, compared to the broader market-2.000.002.004.000.011.38
The chart of Sortino ratio for ASND, currently valued at 0.37, compared to the broader market-6.00-4.00-2.000.002.004.006.000.371.98
The chart of Omega ratio for ASND, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.25
The chart of Calmar ratio for ASND, currently valued at 0.01, compared to the broader market0.002.004.006.000.011.98
The chart of Martin ratio for ASND, currently valued at 0.03, compared to the broader market-10.000.0010.0020.0030.000.035.95
ASND
AAPL

The current ASND Sharpe Ratio is 0.01, which is lower than the AAPL Sharpe Ratio of 1.38. The chart below compares the historical Sharpe Ratios of ASND and AAPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
0.01
1.38
ASND
AAPL

Dividends

ASND vs. AAPL - Dividend Comparison

ASND has not paid dividends to shareholders, while AAPL's dividend yield for the trailing twelve months is around 0.41%.


TTM20242023202220212020201920182017201620152014
ASND
Ascendis Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AAPL
Apple Inc
0.41%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%1.67%

Drawdowns

ASND vs. AAPL - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for ASND and AAPL. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-21.16%
-5.46%
ASND
AAPL

Volatility

ASND vs. AAPL - Volatility Comparison

Ascendis Pharma A/S (ASND) has a higher volatility of 18.14% compared to Apple Inc (AAPL) at 9.59%. This indicates that ASND's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
18.14%
9.59%
ASND
AAPL

Financials

ASND vs. AAPL - Financials Comparison

This section allows you to compare key financial metrics between Ascendis Pharma A/S and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab